Public signalCompany raiseAuto-indexed · Unverified
Eikon Therapeutics, Inc. raised $350.7M
Eikon Therapeutics, Inc.· HAYWARD, US· Biotechnology· Filed Feb 28, 2025
Eikon Therapeutics, Inc. reported raising capital. Based in HAYWARD, CALIFORNIA, US. First sale reported 2025-02-14. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$350.7M
Confidence90%
On the record
- Location
- HAYWARD, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $350.7M
- Target amount
- $400.0M
- Filing date
- Feb 28, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 350,700,037 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Feb 28, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnologyOver $100MCompany Raise
Are you associated with Eikon Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record